miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
- Resource Type
- Academic Journal
- Authors
- Zou, Zhenyou; Zou, Ruyi; Zong, Dan; Shi, Yonghong; Chen, Jinyao; Huang, Jie; Zhu, Jiahui; Chen, Liguan; Bao, Xiaoyan; Liu, Yuan; Liu, Weihao; Huang, Wenhui; Hu, Jingsang; Chen, Zhi; Lao, Xiaojie; Chen, Chaoqun; Huang, Xiaoli; Lu, Yao; Ni, Xueyin; Fang, Daoquan; Wu, Dengqiang; Lu, Shuangshuang; Jiang, Mingzhu; Qiu, Chenyang; Wu, Yuya; Qiu, Qisha; Dong, Yanyuan; Su, Yangyang; Zhao, Chenmin; Zhong, Zhihe; Cai, Jing; Liang, Yong
- Source
- Journal of Cellular and Molecular Medicine. Sep 01, 2017 21(9):1929-1943
- Subject
- Language
- English
- ISSN
- 1582-1838